Momelotinib 100mg tablets
- SNOMED code
42655811000001104- Active compound
- Momelotinib
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Momelotinib dihydrochloride monohydrate, ID: 1366447007
— 100 mg
based on base substance
- Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Omjjara 100mg tablets (GlaxoSmithKline UK Ltd)
Omjjara 100mg tablets
- SNOMED code
42643611000001104- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Omjjara 100mg tablets (GlaxoSmithKline UK Ltd) 30 tablet42643711000001108 ref. pack | 💯 Available Legal category: POM | 050542900066125054290006582End: 05054290006582End: 505429000661205054290010626 | NHS Indicative Price £5,650 | • Hospital |
| — |
Reference packs
Momelotinib 100mg tablets 30 tablet
- SNOMED code
42643511000001103- Quantity and unit
- 30 tablet
- Packs